Tag: patent litigation
Caroline Wagstaff
Jan
8
8
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV certification under the Hatch-Waxman Act lets generic drug makers challenge brand-name patents to speed up affordable drug access. Learn how it works, why it succeeds - and why some drugs stay expensive.
Latest Posts
Popular Posts
-
Extended Use Dates: How the FDA Extends Drug Expiration Dates During Shortages
-
Magnesium Supplements and Osteoporosis Medications: What You Need to Know About Timing
-
Stinging Insect Allergy: What Venom Immunotherapy Really Does for You
-
Meniere’s Diet: How Sodium Restriction and Fluid Balance Reduce Vertigo and Hearing Loss
-
Duloxetine and Liver Health: What You Need to Know About Hepatotoxicity Risk